MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
Li Ren Kong(Nanyang Technological University), Boon Cher Goh(National University of Singapore)
Cited by 51
Related Papers
Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence
|Cancer Research|2014|310
Response to a Novel Multitargeted Tyrosine Kinase Inhibitor Pazopanib in Metastatic Merkel Cell Carcinoma
|Journal of Clinical Oncology|2009|81
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies
|Journal of Clinical Investigation|2023|43
Downregulation of microRNA‑320a inhibits proliferation and induces apoptosis of retinoblastoma cells via targeting TUSC3
|Experimental and Therapeutic Medicine|2020|19